Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letters dated 6th June 2023, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), regarding loss of share certificates of the company. In terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January 2022, the company shall issue 'Letter of Confirmation' to the concerned shareholder after compliance of requisite formalities.
07-06-2023
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Reference is invited to our earlier communication dated 26th April 2023 wherein we had informed about the order and judgement passed by Hon'ble National Company Law Appellate Tribunal ('NCLAT'), New Delhi, on 25th April 2023. The company has appealed against the aforesaid order and judgement, before the Supreme Court of India, New Delhi, on 18th May 2023. The matter was heard before Hon'ble Supreme Court of India on 29th May 2023. The Hon'ble Court has ordered, inter-alia, stay on the contempt proceedings against the company and its directors pending before the Hon'ble National Company Law Tribunal, Chandigarh. The apex court in its order also exhibited the following: - 'Prima facie, it appears that subsequent events have not been taken note of by the NCLT and the NCLAT, despite a clear indication in that behalf in the earlier order of this Court dated 09.07.2019 passed in Civil Appeal No.3165/2010 and connected case.'
30-05-2023
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 29th May 2023, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), comprising information related to issuance of letter(s) of confirmation against duplicate share certificates in electronic mode, in compliance with SEBI Circular No. SEBI/HO/MIRSD/ MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022.
29-05-2023
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 24th May 2023, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), regarding loss of share certificate of the company. In terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January 2022, the company shall issue 'Letter of Confirmation' to the concerned shareholder after compliance of requisite formalities.
24-05-2023
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Secretarial Compliance Report of Morepen Laboratories Limited, issued by Mr. Praveen Dua, Proprietor of M/s. PD and Associates, Practicing Company Secretary, for the financial year ended 31st March 2023.
23-05-2023
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 18th May 2023, received from Registrar and Share Transfer Agent of the company (viz., MAS Services Limited), regarding loss of share certificate of the company. In terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January 2022, the company shall issue 'Letter of Confirmation' to the concerned shareholder after compliance of requisite formalities.
18-05-2023
Bigul

Q4FY23 Quarterly Result Announced for Morepen Laboratories Ltd.

 Pharmaceuticals company Morepen Laboratories announced Q4FY23 results: Company has got three landmark recognitions in last three months including one USFDA approval, one PMDA inspection and one ISO13485 Approval During the current Quarter Q4FY23, the business has stabilised and the consolidated revenues at Rs 367 crore against Rs 372 crore in the same quarter last year. Annual revenues of Rs 1,424 crore have also paced a CAGR of 18% though in the current year revenues of all segments maintained a steady position except Medical Devices. Medical devices business which peaked during covid due to increased demand and inventory buildup has also stabilized in last quarters and is on upward journey. In FY23 the gross revenues at Rs 327 crore were 22% lower than peek of Rs 418 crore in FY22 Formulation Business has catching fast and has registered a jump of 28% in this Quarter. Enhanced focus on marketing and advertising activities for better reach and brand recall, has affected the profitability levels. Result PDF
18-05-2023
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the extracts of standalone and consolidated audited financial results of the company for the quarter and financial year ended 31st March 2023, approved by the Board of Directors on 16th May 2023, are published in the following newspapers: i. Financial Express (English) dated 17th May 2023 ii. Jansatta (Hindi) dated 17th May 2023 The copy of newspaper advertisements are attached herewith and also being made available on the website of the company at www.morepen.com
17-05-2023

Morepen Lab Standalone March 2023 Net Sales at Rs 336.52 crore, down 1.73% Y-o-Y
17-05-2023
Bigul

MOREPEN LABORATORIES LTD. - 500288 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March 2023

 Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed disclosure of Related Party Transactions, for half year ended 31st March 2023 (i.e., from 1st October 2022 to 31st March 2023).
16-05-2023
Next Page
Close

Let's Open Free Demat Account